First-generation mental health apps look to add next-gen AI chatbots
O. Rose Broderick reports on the health policies and technologies that govern people with disabilities’ lives. Before coming…
Cognita CEO on next steps for vision language models in radiology
Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the…
US oil production rose to record high in September, EIA data shows
NEW YORK, Nov 28 (Reuters) – U.S. oil production rose to a record high in September, data from…
We’re reading about Novo Alzheimer’s trials, Bayer stroke results
Good morning, Jason Mast here filling in for Ed. Happy turkey week to all. I, for one, have…
US BEA cancels advance third-quarter GDP estimate
WASHINGTON, Nov 24 (Reuters) – The U.S. Bureau of Economic Analysis said on Monday it had canceled the…
FDA reviewers didn’t get to vote on first priority voucher drug
WASHINGTON — The Food and Drug Administration has promised companies that earn a Commissioner’s National Priority Voucher a one-…
Countries used to test drugs often don’t see the approved medicines, study finds
Numerous medicines are not accessible in many of the countries where they were tested before approval by the…
We’re reading about Trump and patent policies, a new malaria drug
Top of the morning to you, and a fine one it is. Blue skies and comfortable breezes are…
US fourth-quarter GDP could be negative if shutdown drags on, White House economic adviser says
WASHINGTON, Nov 9 (Reuters) – U.S. economic growth in the fourth quarter could be negative if a federal…
Mark Cuban tries to shake up biosimilar pricing with a version of J&J’s Stelara
In its latest bid to shake up the prescription drug market, the Mark Cuban Cost Plus Drug Company…
New FDA priority review vouchers go to Lilly, Novo, Vertex
WASHINGTON — The Food and Drug Administration on Thursday announced the second batch of companies being granted a “Commissioner’s…
Launch prices for new drugs ‘significantly’ exceed inflation, analysis says
Amid intensifying angst over prescription drug prices, a new analysis found that the median net price for 154…